Cargando…
Association between epicardial adipose tissue and adverse outcomes in coronary heart disease patients with percutaneous coronary intervention
We assessed the relationship between the volume of epicardial adipose tissue and long-term outcomes in patients with coronary heart disease (CHD) undergoing percutaneous coronary intervention (PCI). The patients with CHD were followed for at least 2 years after PCI. The epicardial adipose tissue vol...
Autores principales: | Lu, Changqing, Jia, Helei, Wang, Zhentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504663/ https://www.ncbi.nlm.nih.gov/pubmed/30979830 http://dx.doi.org/10.1042/BSR20182278 |
Ejemplares similares
-
High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
por: Lu, Changqing, et al.
Publicado: (2017) -
Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017) -
Epicardial adipose tissue in coronary microvascular dysfunction
por: Duyuler, Serkan, et al.
Publicado: (2022) -
Can epicardial adipose tissue predict coronary artery plaque?
por: Yılmaz, Ömer Hinç, et al.
Publicado: (2015) -
Association between increased epicardial adipose tissue volume and coronary plaque composition
por: Yamashita, Kennosuke, et al.
Publicado: (2013)